Supplementary Data S2 from On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models
posted on 2023-04-04, 02:00authored byHélène Savel, Sandrine Barbier, Cécile Proust-Lima, Virginie Rondeau, Rodolphe Thiébaut, Florence Meyer-Losic, Laura Richert
Details on statistical modeling strategy.
Funding
Ipsen (Ipsen S.A.)
History
ARTICLE ABSTRACT
This work brings new arguments to a controversy on the correct choice of statistical modeling methods for the analysis of MCTs. We conclude that mixed models are more robust than joint models.